Live from the NIH registry
Studies recruiting near Fredericksburg right now
Top 25 of 38 recruiting studies, sorted by proximity — each links to its official registry page
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum
N/A
Interventional 9,500 participants sought
Kaiser Permanente-Caton Hill Medical Center — Woodbridge, Virginia (27.9 mi)
· Sponsor: NRG Oncology
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Kaiser Permanente-Caton Hill Medical Center — Woodbridge, Virginia (27.9 mi)
· Sponsor: SWOG Cancer Research Network
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Atrial Fibrillation (AF)
Phase 3
Interventional 2,500 participants sought
Anthos Investigational site 9817 — Fredericksburg, Virginia (1.5 mi)
· Sponsor: Anthos Therapeutics, Inc.
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
Non-small Cell Lung Cancer
Phase 3
Interventional 876 participants sought
Hematology Oncology Associates of Fredericksburg ( Site 3275) — Fredericksburg, Virginia (1.5 mi)
· Sponsor: Merck Sharp & Dohme LLC
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Kaiser Permanente-Caton Hill Medical Center — Woodbridge, Virginia (27.9 mi)
· Sponsor: NRG Oncology
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD)
Phase 3
Interventional 10,450 participants sought
Mary Washington Hospital — Fredericksburg, Virginia (1.5 mi)
· Sponsor: Eli Lilly and Company
A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
Follicular Lymphoma
Phase 3
Interventional 400 participants sought
Hematology Oncology Associates of Fredericksburg — Fredericksburg, Virginia (1.5 mi)
· Sponsor: Celgene
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Stage III Colon Cancer
Phase 2, Phase 3
Interventional 1,912 participants sought
Kaiser Permanente-Caton Hill Medical Center — Woodbridge, Virginia (27.9 mi)
· Sponsor: NRG Oncology
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
Locally Advanced Urothelial Carcinoma, Metastatic Urothelial Carcinoma
Phase 3
Interventional 320 participants sought
Hematology Oncology Associates of Fredericksburg Inc — Fredericksburg, Virginia (1.5 mi)
· Sponsor: National Cancer Institute (NCI)
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8
Phase 2
Interventional 56 participants sought
Kaiser Permanente-Caton Hill Medical Center — Woodbridge, Virginia (27.9 mi)
· Sponsor: SWOG Cancer Research Network
Product Surveillance Registry
Cardiac Rhythm Disorders, Urological Disorders
N/A
Observational 100,000 participants sought
Research site — Fredericksburg, Virginia (1.5 mi)
· Sponsor: Medtronic
A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)
Non-small Cell Lung Cancer
Phase 3
Interventional 675 participants sought
Hematology Oncology Associates of Fredericksburg ( Site 9550) — Fredericksburg, Virginia (1.5 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
Renal Insufficiency, Chronic
Phase 3
Interventional 2,800 participants sought
Research Site — Woodbridge, Virginia (27.9 mi)
· Sponsor: AstraZeneca
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8
Phase 2
Interventional 66 participants sought
Kaiser Permanente-Caton Hill Medical Center — Woodbridge, Virginia (27.9 mi)
· Sponsor: SWOG Cancer Research Network
Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors
Breast Cancer, Cognitive Impairments
N/A
Interventional 386 participants sought
Kaiser Permanente-Caton Hill Medical Center — Woodbridge, Virginia (27.9 mi)
· Sponsor: NRG Oncology
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Non-small Cell Lung Cancer
Phase 3
Interventional 1,160 participants sought
Research Site — Fredericksburg, Virginia (1.5 mi)
· Sponsor: AstraZeneca
A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Albuminuria in Participants With Chronic Kidney Disease and High Blood Pressure.
Chronic Kidney Disease and Hypertension
Phase 2
Interventional 218 participants sought
Research Site — Woodbridge, Virginia (27.9 mi)
· Sponsor: AstraZeneca
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Breast Cancer
Phase 3
Interventional 3,960 participants sought
Hematology Oncology Associates of Fredericksburg Inc — Fredericksburg, Virginia (1.5 mi)
· Sponsor: NRG Oncology
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Chronic Kidney Disease and Hypertension
Phase 3
Interventional 5,000 participants sought
Research Site — Woodbridge, Virginia (27.9 mi)
· Sponsor: AstraZeneca
INTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)
Polycythemia Vera
Phase 3
Interventional 250 participants sought
Hematology Oncology Associates of Fredericksburg — Fredericksburg, Virginia (1.5 mi)
· Sponsor: Ono Pharmaceutical Co., Ltd.
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
Relapsed or Refractory Multiple Myeloma
Phase 3
Interventional 810 participants sought
Local Institution - 0297 — Fredericksburg, Virginia (1.5 mi)
· Sponsor: Celgene
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Breast Cancer, Metastatic Breast Cancer
Phase 3
Interventional 404 participants sought
Hematology-Oncology Associates of Fredericksburg, Inc — Fredericksburg, Virginia (1.5 mi)
· Sponsor: BriaCell Therapeutics Corporation
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Breast Carcinoma, Colorectal Carcinoma
N/A
Observational 2,000 participants sought
Hematology Oncology Associates of Fredericksburg Inc — Fredericksburg, Virginia (1.5 mi)
· Sponsor: Wake Forest University Health Sciences
A Study of Romiplostim Plus Predniso(lo)ne vs. Predniso(lo)ne Alone for the Treatment of Previously Untreated Primary Immune Thrombocytopenia (ITP)
Primary Immune Thrombocytopenia
Phase 3
Interventional 126 participants sought
Hematology Oncology Associates of Fredericksburg — Fredericksburg, Virginia (1.5 mi)
· Sponsor: Amgen
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8
Phase 2, Phase 3
Interventional 378 participants sought
Kaiser Permanente-Caton Hill Medical Center — Woodbridge, Virginia (27.9 mi)
· Sponsor: SWOG Cancer Research Network